当前位置:在线查询网 > 图书大全 > The Handbook of Clinically Tested Herbal Remedies

The Handbook of Clinically Tested Herbal Remedies_图书大全


请输入要查询的图书:

可以输入图书全称,关键词或ISBN号

The Handbook of Clinically Tested Herbal Remedies

ISBN: 9780789010681

出版社: Haworth Pr Inc

出版年: 2004-7

页数: 500

定价: $ 242.95

装帧: HRD

内容简介


A single source for accurate scientific information on herbal remedies! The Handbook of Clinically Tested Herbal Remedies is the reference tool you need to distinguish those herbal products that have been clinically tested from those for which there is little or no real evidence that substantiates or disputes their claims of efficacy. This essential volume provides a snapshot of 160 herbal products that have been tested in clinical trials. Details of the products and the clinical trials they underwent are here in an easy-to-read, at-a-glance format. Each botanical profile in The Handbook of Clinically Tested Herbal Remedies contains a summary section (table, text and references), followed by product information and clinical trials for that particular product. An evaluation of the strength of the evidence from the trials, along with the context for therapeutics is included to give you a complete picture of each remedy and its usefulness or lack thereof. If there is more than one product based on a particular botanical then the trials are grouped according to the product. This valuable book also makes purchasing easy with manufacturer contact information. With over 30 individual botanicals and 10 multi-ingredient formulas, 160 products and 360 clinical studies, The Handbook of Clinically Tested Herbal Remedies is the book you need to make an informed selection of herbal products. Not only does it list proprietary herbal products that have been tested in controlled clinical studies and provide a rating of the quality of those trials, but, it also describes the fundamentals of herbal medicine, including regulation, characterization, standardization, bioavailability, efficacy, safety, pharmacopoeial monographs as well as incentives, or lack of incentive, for US and European manufacturers to conduct clinical studies.